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To understand how neurons control the expression of the AMPA
receptor subunit GluR2, we cloned the 59 proximal region of the
rat gene and investigated GluR2 promoter activity by transient
transfection. RNase protection and primer extension of rat brain
mRNA revealed multiple transcription initiation sites from 2340
to 2481 bases upstream of the GluR2 AUG codon. The relative
use of 59 start sites was different in cortex and cerebellum,
indicating complexity of GluR2 transcript expression among
different sets of neurons. When GluR2 promoter activity was
investigated by plasmid transfection into cultured cortical neu-
rons, cortical glia, and C6 glioma cells, the promoter construct
with the strongest activity, per transfected cell, was 29.4-fold
(6 3.7) more active in neurons than in non-neural cells. Immu-
nostaining of cortical cultures showed that .97% of the
luciferase-positive cells also expressed the neuronal marker
MAP-2. Evaluation of internal deletion and substitution muta-
tions identified a functional repressor element I RE1-like si-
lencer and functional Sp1 and nuclear respiratory factor-1
(NRF-1) elements within a GC-rich proximal GluR2 promoter
region. The GluR2 silencer reduced promoter activity in glia and
non-neuronal cell lines by two- to threefold, was without effect
in cortical neurons, and could bind the RE1-silencing transcrip-
tion factor (REST) because cotransfection of REST into neurons
reduced GluR2 promoter activity in a silencer-dependent man-
ner. Substitution of the GluR2 silencer by the homologous NaII
RE1 silencer further reduced GluR2 promoter activity in non-
neuronal cells by 30–47%. Maximal positive GluR2 promoter
activity required both Sp1 and NRF-1 cis elements and an
interelement nucleotide bridge sequence. These results indi-
cate that GluR2 transcription initiates from multiple sites, is
highly neuronal selective, and is regulated by three regulatory
elements in the 59 proximal promoter region.
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The AMPA subtypes of glutamate receptors are assembled from
combinations of GluR1, 2, 3 and 4 (GluRA, B, C, D) subunits and
mediate a large fraction of the postsynaptic response at most fast
excitatory synapses in the brain. Studies with recombinant recep-
tors indicate that different subunit combinations produce func-
tionally unique AMPA receptors (Boulter et al., 1990; Sommer et
al., 1990; Hollmann et al., 1991; Lomeli et al., 1994). In particular,
three AMPA receptor properties are strongly influenced by the
level of edited GluR2 expression because of the positively
charged arginine present in the Q/R site of the M2 channel-lining
domain. The presence of edited GluR2 reduces Ca 21 permeabil-
ity (Hollmann et al., 1991; Geiger et al., 1995), voltage-dependent
channel block by cytosolic polyamines (Bowie and Mayer, 1995;
Donevan and Rogawski, 1995; Kamboj et al., 1995; Koh et al.,
1995), and single channel conductance (Swanson et al., 1997).
Thus, EPSPs mediated by GluR2-deficient receptors may be
larger than those mediated by GluR2-rich receptors, which should
have significant physiological consequences.
The relative expression of AMPA receptor subunit mRNA and
protein in certain populations of neurons is not static but may be
remodeled during development (Pellegrini-Giampietro et al.,
1992a), after seizures or ischemic insult (Pellegrini-Giampietro et
al., 1992b, 1994; Pollard et al., 1993; Freidman et al., 1994;
Kamphuis et al., 1994; Prince et al., 1995) and after administra-
tion of antipsychotics (Fitzgerald et al., 1995), drugs of abuse
(Ortiz et al., 1995; Fitzgerald et al., 1996), or corticosteroids (Nair
et al., 1998). After ischemia, a drop in relative GluR2 expression
in hippocampal CA1 pyramidal cells is associated with changes in
AMPA receptor properties consistent with an increase in GluR2-
deficient receptors (Gorter et al., 1997), although whether GluR2
selectively declines remains controversial (see Frank et al., 1995).
Recent work from our laboratory indicates that the number of
GluR2 subunits in a receptor is variable and that the relative
abundance of GluR2 affects Ca21 permeability and rectification
differentially (Washburn et al., 1997). Given that distinct popu-
lations of neurons are known to be GluR2-deficient or GluR2-
rich (Bochet et al., 1994; Jonas et al., 1994; Geiger et al., 1995;
Washburn et al., 1997), the consequences of modulating GluR2
expression in these cells will depend on pre-existent GluR2 levels.
These studies indicate that mechanisms controlling the level of
GluR2 expression may be important regulatory determinants of
AMPA receptor phenotype. GluR2 expression in brain is pri-
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marily restricted to neurons (Monyer et al., 1991; Petralia and
Wenthold, 1992; Sato et al., 1993), although AMPA receptor
subunits are expressed by certain populations of glia (Keinänen et
al., 1990; Burnashev et al., 1992) and O-2A progenitor cells
(Patneau et al., 1994). Functional promoter studies of NMDA
and kainate receptor genes have been reported (Bai and Kusiak,
1995; Sasner and Buonanno, 1996; Huang and Gallo, 1997;
Suchanek et al., 1997), and the organization of the mouse GluR2
gene has been described (Köhler et al., 1994), but no regulatory
elements of AMPA receptor subunits have yet been identified.
We show here that the GluR2 proximal promoter region contains
a negative regulatory element and a positive regulatory region
and directs the neural-specific expression of a luciferase reporter
gene in transiently transfected primary cortical cultures.
Parts of this paper have been published previously in abstract
form (Peters et al., 1995; Myers et al., 1996).
MATERIALS AND METHODS
Materials. Rat C6 glioma (CCL-107) cells were obtained from American
Type Culture Collection (Rockville, MD). HeLa cells were a gift from
Dr. T. J. Murphy (Emory University). Timed-pregnant rats were pur-
chased from Harlan Sprague Dawley (Indianapolis, IN). DMEM and
MEM tissue culture media, L-glutamine, trypsin, and EDTA were ob-
tained from Life Technologies (Gaithersburg, MD). Poly-D-lysine (mo-
lecular weight of . 60,000), fetal bovine serum, and tissue culture
supplements human transferrin, putrescine, tri-iodothyronine, progester-
one, estradiol, sodium selenite, insulin, L-glucose, and sodium bicarbon-
ate were obtained from Sigma (St. Louis, MO). Mouse monoclonal
anti-MAP-2 (clone AP20) was purchased from Boehringer Mannheim
(Indianapolis, IN), mouse monoclonal anti-GFAP (clone G-A-5) was
from Sigma, polyclonal rabbit anti-luciferase was from Promega (Madi-
son, WI), and Texas Red-conjugated F(ab9)2 donkey anti-rabbit IgG and
FITC-conjugated F(ab9)2 donkey anti-mouse IgG were from Jackson
ImmunoResearch (West Grove, PA). Anti-Sp1 and anti-Krox-24 anti-
bodies and Sp1 and Krox-24 double-stranded oligonucleotides were pur-
chased from Santa Cruz Biotechnology (Tebu, France).
Pfu polymerase and the l DASH II genomic library were from
Stratagene (La Jolla, CA). Lipofectamine, Superscript II reverse tran-
scriptase, and RNAsin were obtained from Life Technologies. MMLV
reverse transcriptase was from Stratagene. Restriction enzymes were
purchased from New England Biolabs (Beverly, MA) or Life Technolo-
gies. T4 DNA ligase, T4 DNA and Klenow polymerases, RNaseONE,
luciferase vectors, and assay reagents were purchased from Promega.
pcDNA3 and TA cloning vectors were from Invitrogen (San Diego, CA),
and Sequenase 2.0 was purchased from United States Biochemicals
(Cleveland, OH). Geneclean kits were obtained from BIO 101 (La Jolla,
CA). All oligonucleotides were synthesized in house on a MilliGen/
Biosearch Cyclone Plus DNA Synthesizer using Expedite Chemistry
(PerSeptive Biosystems). Radioisotopes were purchased from Amersham
(Arlington Heights, IL). Nylon-backed nitrocellulose membranes were
purchased from Bio-Rad (Hercules, CA). Other general salts and sup-
plies were purchased from Sigma or Fisher Scientific (Houston, TX).
Isolation and characterization of genomic clones. Approximately 0.7 3
10 6 plaques from a rat genomic library in l DASH II were hybridized on
nylon membranes with a 3505 bp EcoRI-XhoI restriction fragment con-
taining the full coding sequence of the rat GluR2 cDNA, labeled with
[a-32P]dCTP by random priming. Three positive plaques were purified
and subjected to a second round of hybridization with an end-labeled
oligonucleotide (R2–1; GAGGACAGAAATATGCATAATCTTTTG-
CAT) complementary to the first 10 codons of the GluR2 coding se-
quence (Boulter et al., 1990). A single recombinant phage obtained from
this screen had an 18 kb insert that included a long, interspersed repeat
segment (LINE-1) at its immediate 59 end, ;9 kb upstream of the 59 end
of the GluR2 gene. A 1.64 kb XbaI-HindIII fragment, which contained
the GluR2 proximal promoter region, exon 1, and 288 bp of the first
intron, has been deposited in the GenBank database (accession number
AF025917).
59 RACE, RNase protection, and primer extension and Southern blot.
For 59 RACE, poly(A 1) mRNA isolated from adult male Sprague
Dawley rat brains by the method of Chirgwin et al. (1979) was reverse
transcribed by MMLV reverse transcriptase from the R2–1 primer. After
addition of an oligo-dC tail with terminal deoxynucleotidyltransferase,
PCR reactions were performed using the anchor primer provided by the
Life Technologies 59 RACE system, plus the R2-race1 primer (AGTC-
CCGAGGACTGGCTGAA) complementary to nucleotides 81–100 of
the GluR2 cDNA sequence (Boulter et al., 1990). PCR products were
subcloned into the TA cloning vector and selected by colony hybridiza-
tion to the R2–20 oligonucleotide complementary to bp 64–83 of the
GluR2 cDNA (GAATGCAGTTTTTAGCTGAG). Ten clones were se-
lected by size on agarose gels and sequenced through the anchor-priming
site to locate 59 ends of the mRNA.
For primer extension, an oligonucleotide (PER2–3; TCCCAGTTG-
TAGCTGGTGGCTGTTGATGCC) complementary to bp 2163 to
2192 from the coding AUG (see Fig. 1 A) was end-labeled with
[g-32P]ATP (;4.8 3 10 5 cpm/pmol) and annealed to 30 mg of adult rat
cortical and cerebellar total RNA in 20 mM HEPES, pH 7.0, 350 mM
NaCl, and 50% formamide at 50°C for 24 hr. Annealed samples were
precipitated and resuspended in 50 ml containing 50 mM Tris-HCl, pH
8.3, 75 mM KCl, 3 mM MgCl2 , 2.5 mM dNTPs, 10 mM DTT, 50 mg/ml
actinomycin D, 20 units RNAsin, and 200 units Superscript II reverse
transcriptase and were incubated at 42°C for 90 min; then 1 ml of
RNAsONE was added, and the incubation continued for an additional 35
min. Samples were recovered and loaded onto a sequencing gel. Yeast
total RNA (48 mg) and an in vitro synthesized full-length GluR2 sense
RNA (10 ng) were used as templates in negative and positive control
reactions, respectively. The in vitro GluR2 RNA includes 481 bases of
GluR2 59-untranslated region (UTR) sequence plus an additional 40 bp
of polylinker sequence. To confirm the specificity of the primer extension
reactions, we also prepared Southern blots of primer extension products.
For these experiments the reaction conditions were identical to those
described above except that the oligonucleotide primer was unlabeled
and, after gel resolution, reaction products were electrotransferred to a
nylon membrane. Southern blots were then hybridized with a 32P-
radiolabeled DNA probe (.10 8 cpm/mg) made from bp 2192 through
2481 relative to the GluR2 AUG (see Fig. 2 A, probe B). Hybridized
blots were washed under high-stringent conditions and exposed to a
Molecular Dynamics PhosphorImager plate (Sunnyvale, CA) for
visualization.
RNase protection experiments were conducted using an Ambion RPA
kit (Austin, TX) following the manufacturer’s instructions. For identifi-
cation of mRNA 59 ends, an antisense riboprobe complementary to
nucleotides 2192 through 2481 relative to the GluR2 AUG (see Fig. 2 A,
probe C) was radiolabeled and annealed (5 3 10 5 cpm per reaction) to
30 mg of adult rat cortical and cerebellar total RNA in 20 ml of hybrid-
ization solution (Ambion kit) at 45°C overnight. Annealed samples were
digested with RNase A and RNaseT1, resolved on an RNA-sequencing
gel, and exposed to Kodak X-OMAT film for 12 hr. To quantify the
relative use of transcription initiation sites in cerebellum and cortex, an
antisense RNA probe complementary to bases 2136 through 2361
relative to the GluR2 AUG (see Fig. 2 A, probe D) was annealed to total
RNA as described above. This probe identifies the major short transcrip-
tion initiation site at 2340 and also summates all transcripts with 59 ends
extending beyond 2360 into a single band on the gel. Total RNA used in
these experiments was prepared independently from four adult male
Sprague Dawley rats.
Methylation sites in the promoter reg ion. Adult rat genomic DNA was
isolated from lung, kidney, cortex, and cerebellum (40 –50 mg) and
digested with AccI to release a 1.3 kb promoter fragment (2731 to 1603
bp relative to the 11 transcription initiation site) and then was digested
again with one of the methylation-sensitive restriction enzymes BssHII,
SacII, AvaI, or Eco47III. Southern blots of the genomic fragments were
prepared and hybridized with an AccI-restricted 1.3 kb genomic fragment
radiolabeled with [a-32P]dCTP by random priming (.10 8 cpm/mg).
All hybridizations and washes were conducted under high-stringent
conditions.
Cell culture. Primary rat cortical neuronal cultures were prepared from
embryonic day 18 fetal rat pups resected from pregnant Sprague Dawley
rats. Briefly, cerebral cortices were minced in DMEM supplemented
with 1.1 gm/l glucose, 2.1 gm/l NaHCO3 , and 1.84 mM L-glutamine, pH
7.25 (FDMEM); 1 ml of fetal bovine serum (FBS) was added; and tissue
was dissociated by trituration. Dissociated cells were rinsed in 8 ml of
FDMEM media, pelleted at low speed for 5 min, and then resuspended
in FDMEM supplemented with 100 mg/ml human apotransferrin and
(in mM): insulin 0.5, putrescine 60, tri-iodothyronine 1 3 10 23,
b-estradiol 1 3 10 26, progesterone 0.01, and sodium selenite 0.03
(termed TFDMEM). Cortical cells were plated at a density of 0.7–1.0 3
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10 6 cells/well into Falcon 12-well culture dishes precoated overnight with
180 mg/ml poly-D-lysine and coated with 20% FBS in FDMEM for 2–3
hr before plating. Cultures were grown for 3–6 d in vitro, without media
change, in an humidified, 5% CO2 , 37°C incubator. It should be noted
that these cultures are a mixture of neurons and glia with ;60% of cells
MAP-2 positive on days 4–6 in culture.
Primary glial cultures were generated from the primary cortical neu-
ronal cultures by repeated washing of cells with FDMEM plus 10% FBS
over a period of 1–4 weeks after plating or by passage of cultures to
facilitate the elimination of neurons. Cortical glia and rat C6 glioma cells
were grown in FDMEM plus 10% FBS until use in transfections. HeLa
cells were grown in DMEM supplemented with 10% FBS and 2 mM
glutamine. The non-neuronal cultures were grown in the same incubator
as the neurons.
Constructs and mutagenesis. To generate 59- and 39-GluR2 promoter
deletion constructs, we amplified specific-length fragments of the GluR2
promoter by PCR with Pfu polymerase using oligonucleotides comple-
mentary to the GluR2 1.64 kb XbaI-HindIII GluR2 fragment. 59- and
39-oligonucleotides contained NheI and BglII restriction sites, respec-
tively. Amplified DNA fragments were restricted and cloned into the
NheI and BglII sites of the pGL2 basic vector upstream of the reporter
gene firefly luciferase. Recombinants were analyzed by restriction and
sequence analysis to confirm the location of the GluR2 promoter bound-
aries. Throughout this report, construct boundaries [i.e., R2(2822/
1320)luc] are defined relative to the 59-most major initiation site identified,
2429 bases upstream from the recognized GluR2 AUG.
To generate internal GluR2 silencer mutations in the context of the
R2(2302/1320)luc construct, we used a two-round PCR mutagenesis
protocol as described (Cormack, 1997). After the second-round PCR
reaction, the mutagenized DNA fragment was restricted with NheI and
BglII and cloned back into the pGL2 basic vector. To delete the GluR2
silencer, we replaced 25 bp spanning the silencer element with an NsiI
restriction site. This construct is designated R2(2302/1320)luc-DB. Sub-
stitution mutations were introduced by replacing different 6 bp segments
of the silencer with either an EcoRI or an EcoRV restriction site and
were designated R2(dRI)luc and R2(dRV)luc, respectively. Constructs
that replaced the GluR2 silencer with the Type II Na channel repressor
element 1 (NaII-RE1) silencer in the context of the GluR2 promoter
[R2(dNaII)luc], or likewise replaced the NaII-RE1 element with the
GluR2 silencer in the context of the NaII promoter [NaII(dR2)luc], were
also made using the two-round, oligonucleotide-directed PCR mutagen-
esis protocol. The NaII promoter construct without an RE1 element
(pMB4) (Kraner et al., 1992) was excised with EcoRI, blunted with
Klenow, cloned into the SmaI-digested pGL2 basic vector, and renamed
NaII(D)luc. The NaII promoter construct retaining the RE1 silencer on
a 118 bp fragment (21051 to 2933) fused 59 of the NaII minimal
promoter region (2134 to 1177) as described (pSDK7) (Kraner et al.,
1992) and was cloned upstream of firefly luciferase by shuttling it through
the pBluescript HindIII-PstI polylinker sites and into the pGL2 basic
vector KpnI and NheI sites. This construct was renamed NaIIluc. All
constructs described were confirmed by restriction and sequence analysis
and preserved the correct flanking sequences and silencer orientations of
their natural promoter contexts; e.g., R2(dNaII)luc contains type II
sodium channel RE1 silencer with GluR2 flanking sequence and the
GluR2 antisense orientation. The pairs of oligonucleotides used to
introduce these mutations are the following: to delete the silencer in
GluR2, R2(2302/1320)luc-DB, sense TCCGACTATGCATCGGAT-
GCGCAACAC and antisense GCATCCGATGCATAGTCGGAGC-
TCTGG; the missense mutation R2(dRI)luc, sense AAAGCGCTGT-
GAATTCTGCTAAAATCGGATGCG and antisense CCGATTT-
TAGCAGAATTCACAGCGCTTTAGTCGG; the missense mutation
R2(dRV)luc, sense CTAAAGGATATCCCTCGGTGCTAAAATCGG
and antisense CCGAGGGATATCCTTTAGTCGGAGCTC; to place
the NaII RE1 silencer in the GluR2 promoter, R2(dNaII)luc, sense
TGCTGTCCGTGGTTCTGAAATCGGAT and antisense AGAAC-
CACGGACAGCACTTTAGTCG; to place the GluR2 silencer in the
NaII promoter, NaII(dR2)luc, sense GCACCGAGGACAGCGCTA-
GAGTCTCTGAAT and antisense GCTGTCCTCGGTGCTAAAA-
CCCAATTACAG.
A two-round PCR mutagenesis strategy was also used to introduce
systematically internal deletions of 25–30 bp in the R2(2302/1320)luc
construct to generate a “deletion scan” of the proximal region of the
GluR2 promoter. For each new mutagenized construct, a unique 6 bp
restriction (EcoRV, NsiI, or StuI) site was introduced to allow easy
identification of recombinants. All mutant constructs were sequenced for
verification. The designations for the internal deletion mutants are
R2(2302/1320)luc-DA through DN, and the following GluR2 promoter
regions are deleted: DA, 2227 to 2197; DB, 2196 to 2172; DC, 2171 to
2147; DD, 2146 to 2118; DE, 2117 to 290; DF, 289 to 265; DG, 264
to 240; DH, 239 to 215; DI, 214 to 114; DJ, 115 to 138; DK, 23 to
174; DL, 171 to 1146; DM, 1107 to 1206; and DN, 1182 to 1206.
Oligonucleotide sequences used to introduce internal mutations for the
R2(2302/1320)luc deletion scan are available on request.
Transfections. Primary neurons were transfected on days 3–6 after
plating. Primary glia were transfected either as confluent, unpassaged
cells or at 90% confluency 2–3 d after passage, and C6 glioma cells were
transfected similarly at 80–100% confluency. All transfections were con-
ducted in Falcon 12-well dishes with Lipofectamine according to the
manufacturer’s instructions. Per well, 1 mg of DNA, 50 ml of 150 mM
NaCl, and 5 ml of Lipofectamine were combined in 0.5 ml of TFDMEM
media and incubated with cells at 37°C for 5 hr. After transfection, the
DNA and Lipofectamine mixture was replaced with fresh TFDMEM
(0.5 ml) for primary neuronal cultures or with normal culture media for
primary glia, C6 glioma, and HeLa cells. Twenty-four hours later, cells
were rinsed with PBS and harvested by lysis. Cell lysates were cleared by
centrifugation and assayed for luciferase activity in a Turner TD-20e
luminometer. A preliminary time course study with the GluR2, cytomeg-
alovirus (CMV), and SV40 promoters in transfected cortical cultures
indicated that luciferase expression was maximal 24 hr after transfection
and decreased slowly by 48 and 72 hr.
For cotransfections, a similar protocol was used except the amount of
Lipofectamine was increased to 7.5 ml per well to accommodate the
additional DNA. The amount of the GluR2 promoter–firefly reporter
construct was varied from 0.1 to 1.0 mg/well, and the amount of the
RE1-repressor factor plasmid (RESTexpress) (Chong et al., 1995) or the
control plasmid pcDNA3 was held fixed at 0.25 or 0.75 mg/well, and pBS
vector was added to adjust the total DNA for all transfections to a final
concentration of 1.75 mg/well. Under these cotransfection conditions, the
amount of luciferase activity recovered in the cell lysates varied linearly
with the amount of pGL2 reporter plasmid DNA transfected (data not
shown). For nuclear respiratory factor-1 (NRF-1) cotransfections, 1 mg
of pNRF-1 plasmid (Virbasius et al., 1993) was mixed with 0.5 mg of the
GluR2 promoter–reporter construct .
All plasmid DNA preparations were prepared from 100 ml of 2xYT
cultures using Qiagen Maxi-DNA Prep columns. At least three indepen-
dent DNA preparations for each construct were transfected, in parallel,
in each experiment. Each individual DNA plasmid was transfected into
triplicate wells. For transfections into multiple cell types, a master mix of
the plasmid DNA, NaCl, Lipofectamine, and TFDMEM media was
prepared from which equal aliquots were delivered to the cells. In all
experiments, an SV40-luciferase or a CMV-luciferase control plasmid
was transfected into parallel wells to normalize GluR2 promoter activity
across multiple experiments and primary culture preparations. Where
indicated, luciferase activity was converted to moles of luciferase (;2.2
Turner light units/10 218 mole) using a standard curve generated with
recombinant firefly luciferase under our assay conditions.
Immunofluorescence. Primary neurons prepared as described above
were plated onto glass coverslips precoated with both poly-D-lysine
(overnight) and then fibronectin (20 mg/ml; 1–2 hr). Cultures were
transfected with the R2(2302/1320)luc or the R2(2134/1147)luc con-
struct and fixed 24 hr later with 4% paraformaldehyde in PBS for 15 min.
Cells were rinsed three times with PBS, permeabilized with 0.1% w/v
Triton X-100 in PBS for 5 min, washed, and then incubated in staining
buffer (2% horse serum in PBS) for 15 min. Cells were incubated for 2 hr
in staining buffer with rabbit anti-luciferase (1:200) and either mouse
anti-GFAP (1:800) or mouse anti-MAP-2 (1:600) and then rinsed four
times for 5 min each with excess staining buffer before incubation with
the secondary antibodies, Texas Red-conjugated donkey anti-mouse IgG
(1:250) and FITC-conjugated donkey anti-rabbit IgG (1:250), in staining
buffer for 30 min. Cells were rinsed four times for 5 min each as
described above and mounted onto glass slides. All washes and staining
incubations were conducted at room temperature. Fluorescence was
visualized with a Zeiss Axioplan microscope using a 403 Plan-
NEOFLUAR oil objective and appropriate fluorescent filters. Cells
positively identified for firefly luciferase expression were counted and
scored for positivity to either MAP-2 or GFAP expression.
Nuclear extract and gel mobilit y shif t assays. Nuclear extracts were
prepared from cultured cells according to the method of Dignam et al.
(1983). For gel mobility shift assays, complementary oligonucleotides
were purified by denaturing PAGE and then annealed and 32P-labeled by
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Klenow fill-in of the 59 overhangs for 25 min at room temperature.
Labeled probes were extracted, purified through a spin column, precip-
itated, and stored in deionized water at 4°C until use.
In vitro binding reactions were conducted in 20 ml volumes containing
(final concentrations) 12 mM HEPES, pH 7.9, 4 mM Tris-HCl, pH 7.9, 60
mM KCl, 1 mM EDTA, 12% v/v glycerol, 1 mM DTT, 1 mM PMSF, 0.225
mg/ml BSA, 0.1 mg/ml poly dI:dC, and 5–10 mg of nuclear extract protein.
Individual components of the binding reaction were combined and incu-
bated on ice for 15–30 min before the addition of probe (;0.3 nM, final
concentration; 10–30 3 10 3 cpm) and then were incubated at 22°C for 15
min. Where indicated, a 30–200-fold excess of cold competitor oligonu-
cleotides was added on ice 15–30 min before addition of probe. After
incubation, samples were separated on a 4% polyacrylamide, Tris-
glycine, glycerol gel. Dried gels were exposed to Kodak X-OMAT film or
to a Molecular Dynamics PhosphorImager plate for visualization.
Double-stranded oligonucleotide probes used in the binding reactions
are the following (top strand): probe G, GGCGCTGTGCGGGG-
GAGGGGTAGGTGCGCGA; probe H, CTAGAGCTCCCTGCCT-
GCCTTGAGTCGGATC; Sp1 consensus, ATTCGATCGGGGCGG-
GGCGAGC; dg1 mutant, GGCGCTGTGCTCTAGAGGGGTAGGT-
GCGCGA; and Krox-24 consensus, GGATCCAGCGGGGGCGAG-
CGGGGGCGA.
Statistical analysis. For comparison of the promoter activities between
two or more constructs within a given cell type, at least three plasmid
preparations for each construct were transfected in the same experiment.
The order in which individual plasmid DNA preparations were added to
the wells for transfection was randomized to reduce bias attributable to
handling of the cells during the procedure. Raw luciferase activity was
normalized to the activity of either the SV40 promoter or a defined
control construct measured in parallel wells. Data from multiple exper-
iments (culture preparations) were combined and analyzed by ANOVA
followed by post hoc Dunnett’s tests for significance between means or,
when appropriate, Student’s t tests. Comparisons of the promoter activ-
ities between constructs were made within, and not across, cell types.
RESULTS
Multiple tissue-specific transcription initiation sites
and DNA methylation
Exon 1 and the proximal 59-flanking sequence of the rat GluR2
gene are shown in Figure 1A, along with a schematic identifying
the salient features. To identify transcription initiation sites, we
first conducted 59 RACE analysis of rat brain mRNA. Multiple
potential initiation sites were identified from 2286 to 2481 bases
upstream from the GluR2 translation AUG codon. Most RACE
59 ends mapped to one of two clusters, from 2286 to 2295 or
from 2419 to 2427 bp, with one end residing at 2481 bp (Fig.
1A, open triangles). The sequence of each RACE PCR product
matched that of the genomic DNA up through the anchor-
priming site, reducing the likelihood that an intron resides in the
GluR2 59-UTR, in accordance with previous observations for the
mouse GluR2 gene (Köhler et al., 1994).
To further identify potential sites of transcription initiation in
the GluR2 gene, we used both primer extension and RNase
protection analysis of adult rat brain RNA (Fig. 2). Primer
extension analysis on cortical RNA using an oligonucleotide,
PER2–3 complementary to the GluR2 59-UTR, revealed multiple
reaction products extending from 2312 to 2452 nucleotides
upstream from the GluR2 AUG (Fig. 2B). None of these cortical
RNA primer extension products appeared in parallel reactions
conducted with an in vitro synthesized genomic GluR2 RNA
control (Ctl) that includes putative 59-UTR sequence from 21
through 2481 bases; this positive control also includes an addi-
tional 40 bp of non-GluR2 polylinker sequence (Fig. 2B, lef t
lane). This result indicates that the multiple extension products
observed in cortical RNA reactions are not the result of RNA
secondary structure preventing the processivity of reverse tran-
scriptase. To determine which PER2–3 primed extension prod-
ucts from cortical RNA were derived from GluR2, a parallel
primer extension reaction was run using unlabeled PER2–3 oli-
gonucleotide as primer. Products from this reaction were then
Southern blotted onto a nylon membrane and hybridized with
probe B, DNA complementary to bases 2192 through 2481 59 of
the GluR2 AUG (Fig. 2A). The results of this Southern blot,
depicted in the right lane of Figure 2B, confirm the identity of
nine GluR2 primer extension products. A single reaction product
at 2312 was not confirmed by the Southern blot and is presum-
ably an artifact caused by extension from a non-GluR2 transcript.
We also conducted RNase protection assays on rat cortical and
cerebellar RNA to confirm the primer extension findings. Using
an antisense RNA probe (2192 through 2481 bp of the GluR2
leader, probe C in Fig. 2A), we again detected multiple bands
predicting different GluR2 59 ends in the cortex and cerebellum,
and these bands were in agreement with results obtained by
primer extension (Fig. 2C). Major RNase-protected 59 ends
mapped to 2340, 2368, 2399, and 2429 bp 59 of the GluR2
AUG codon, with additional minor ends mapping to 2452 and
2481 bp. Because the riboprobe in this experiment included
GluR2 sequence only to position 2481 bp, the 2481 band ob-
served at the top of the gel (Fig. 2C, Cb and Ctx lanes) is a
summation of all natural GluR2 transcripts with 59 leaders at least
this long. Despite this, however, the intensity of the 2481 band
was much weaker than that observed for shorter, more dominant
mRNA species, indicating that long transcripts were few in num-
ber. From these analyses, it seems that GluR2 initiates transcrip-
tion from multiple dominant sites between 2340 and 2429 bases
upstream of the GluR2 AUG, with a minority of transcripts
initiating at 2452 and 2481 bases. Therefore, depending on the
site of transcription initiation, GluR2 mRNAs will contain a
variable-length and unusually long 59-UTR leader sequence
(Kozak, 1987), a GC-rich 59 end, an imperfect GU repeat (40
nucleotides), and two to five upstream, out-of-frame AUG codons
(Fig. 1A).
Although the banding pattern observed in cerebellar RNA was
similar to that in cortical RNA in the RNase protection assays,
longer transcripts appeared to predominate in the cerebellum
(Fig. 2C). To address this further, an RNase protection probe,
probe D (Fig. 2A), was designed that summates all transcripts
2360 bases and longer into a single protected band. This probe is
also partially protected by the major 2340 transcript population.
By hybridizing this RNA probe to total cortical and cerebellar
RNA derived from each of four rats in separate reactions, we
quantified the amount of long GluR2 transcripts (2360 and
longer) relative to the amount of short GluR2 transcripts (2340)
as shown in Figure 2D. The ratio of long to short GluR2 tran-
scripts was greater in the cerebellum than in the cortex in each of
the four rats tested (Fig. 2D; p , 0.05, paired t test). These results
indicate that GluR2 initiation site usage differs between these two
brain regions and in a strict sense supports the conclusion that the
GluR2 gene contains multiple promoters.
We have designated the 59-most dominant transcription initia-
tion site, approximately 2429 bases from the GluR2 AUG, the
11 initiation site. All plasmid constructs used in evaluating
GluR2 promoter activity by transient transfections are defined
relative to this site. Our designated 11 nucleotide for the rat gene
is in agreement with the 59-most start site identified for the mouse
GluR2 gene (Köhler et al., 1994), but there is clear evidence of
minor transcriptional initiation sites further upstream and addi-
tional major sites downstream; indeed, 59 initiation sites are
dispersed over .141 bp of the GluR2 promoter region.
The GluR2 promoter region displays several areas of high
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(86%) and low (14%) GC content (Fig. 1B, right). The region of
highest GC content spans ;150 bp adjacent to the 11 site,
includes some of the identified transcription initiation sites, and
identifies a CpG island that could be subject to regulation by
methylation in vivo. Indeed, when genomic DNA isolated from
adult rat cortex, cerebellum, lung, and kidney was codigested with
AccI and one of the methylation-sensitive enzymes SacII,
Eco47III, or BssHII, only the SacII site at 2568 bp was found
methylated in a tissue-specific manner. This SacII site was fully
methylated in kidney (Fig. 1B, 1.3 kb band) and lung (data not
shown) genomic DNA but only partly methylated in DNA ex-
tracted from the cortex (Fig. 1B) and cerebellum (data not
shown). In contrast, Eco47III and BssHII restriction sites were
unmethylated in all four tissues tested (data not shown). The
SacII digestion pattern in cortex may be attributable to a combi-
nation of methylated glial DNA and unmethylated neuronal DNA
in the sample, or it may reflect methylation of a single GluR2
allele. Although methylation of CpG dinucleotides increases the
informational content of genes, the biological significance of the
tissue-specific methylation of the GluR2 promoter remains to be
addressed.
The GC-rich proximal area also contains consensus recogni-
tion sequences for Sp1/Krox-24 and the NRF-1 transcription
factors (Fig. 1A, box areas). The regulatory role of these cis
Figure 1. Features of the rat GluR2 promoter and 59-flanking region. A, Schematic showing the salient features of the GluR2 promoter region and
partial nucleotide sequence of the GluR2 59 proximal promoter region, exon 1, and part of intron 1. The exon 1 sequence is in uppercase with the 59
promoter and intron 1 sequences in lowercase letters. mRNA 59 ends identified by 59 RACE analysis are indicated by open triangles, and those identified
by RNase protection and primer extension are indicated by solid or gray circles, respectively. The 59-most prominent initiation site has been designated
as the 11 transcription initiation site, located 429 bases 59 of the GluR2 AUG (bent arrow). Consensus cis element sequences for the GluR2 silencer
element and Sp1/Krox-24 and NRF-1 transcription factors are identified by name adjacent to the corresponding boxed sequence. The boundaries of the
initiation site region and the location of the methylated CpG dinucleotide (CpG m; filled diamond) are indicated in the schematic. The location of the
antisense PER2–3 oligonucleotide used for primer extension reactions is indicated by double underlining below the nucleotide sequence. B, GC content
of the GluR2 promoter and exon 1 and a methylation-sensitive Southern blot. The average GC content 6 10 bp surrounding a central nucleotide was
calculated and plotted along the length of the GluR2 promoter. The dashed line represents the average GC content (49.7%) for the whole 1.35 kb GluR2
promoter sequence shown. Open triangles, solid circles, and gray circles refer to RACE, RNase protection, and primer extension sites, respectively, as
described in A. The solid and open horizontal bars above the GC plot represent the location of the GluR2 silencer and the Sp1/Krox-24 and NRF-1
regions, respectively. Also shown are the locations of CpG dinucleotides in the GluR2 promoter. The methylation state of the CpG dinucleotides was
evaluated by sensitivity to SacII, Eco47III, and BssHII restriction digestion and represented by S, E, and B, respectively. The filled diamond represents
a methylated CpG dinucleotide in kidney and lung but not in cortex and cerebellar DNA, whereas open diamonds indicate unmethylated CpGs in the
DNA from all four tissues. The blot at lef t is an example of an AccI- and SacII-restricted Southern blot showing tissue-specific SacII digestion in cortex
(Ctx) but not in kidney (Kid) DNA; lung and cerebellar Southern blots are not shown. The 1.3 kb fragment between the two AccI sites (A) was
radiolabeled as probe.
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elements is evaluated below. Regions more distal from the 11 site
exhibit a low GC content, minimal at consensus TATA box
sequences at 2760 and 2361 bp and also at the GluR2 initiation
AUG codon (Fig. 1). No TATA box element is near any of the
transcriptional initiation sites identified. A weak consensus se-
quence for the pyrimidine-rich initiator element lies near the
major 59 initiation site cluster at bp 13 to 111 (Javahery et al.,
1994). The absence of a TATA box near transcription initiation
sites is a common feature in mammalian genes, including gluta-
mate receptor genes such as NR1, NR2B, NR2C, and KA-2 (Bai
and Kusiak, 1993; Suchanek et al., 1995; Sasner and Buonanno,
1996; Huang and Gallo, 1997), and mouse GluR2 (Köhler et al.,
1994). Overall, the nucleotide sequence similarity between the
mouse and rat GluR2 promoter regions is high with a 90–95%
sequence identity over 1.2 kb of the proximal promoter region,
including 0.8 kb 59 of the 11 transcription initiation site.
Identification of a minimal promoter region
We generated a series of 59- and 39-GluR2 promoter deletion
constructs and transfected these into primary cortical and pri-
mary glial cultures to define the boundaries of a minimal GluR2
promoter region and to identify cis elements that govern the
cell-specific expression of GluR2. These constructs were also used
to evaluate the role of consensus TATA and CAAT box se-
quences residing upstream in the GluR2 59 promoter. Whether
deletions were made from the 59 or the 39 side, substantial
Figure 2. Differential use of transcription initiation sites in rat cortex and cerebellum. A, Schematic of the 59 region of the GluR2 gene. Base positions
indicated are relative to the GluR2 AUG codon, and identified transcription initiation sites are indicated by gray and solid circles as described in the
Figure 1A legend. The location of the PER2–3 oligonucleotide used for primer extension and probes B, C, and D are shown. Probes B and C encode
identical sequence except probe B was a DNA probe used in the Southern blot and probe C was an antisense RNA used for RNase protection. Probe
D was an RNA probe used for RNase protection experiments. B, Primer extension ( p.e.) of rat cortical RNA and Southern blot (s.b.). The 32P-labeled
PER2–3 oligonucleotide-primed extension products from 30 mg of cortical RNA (middle lane) are shown. Multiple bands are observed in cortical RNA
(Ctx) reactions ranging from 2312 to 2452 bases 59 of the GluR2 AUG; none of these bands was observed in the control GluR2 in vitro synthesized RNA
reactions (lef t lane), indicating that secondary structure does not account for the multiple bands observed in cortical RNA reactions. When the cortical
primer extension products, derived from a separate reaction that used unlabeled PER2–3 oligonucleotide as primer, were Southern blotted and
hybridized with probe B, all extension products, except the shortest, were positively identified as GluR2 (right lane). C, RNase protection of 30 mg of adult
cortical (Ctx) and cerebellar (Cb) RNA. Probe C detected multiple GluR2 59 ends both in cerebellar (middle lane) and cortical (right lane) RNA. The
banding pattern shown here is nearly identical to that observed by primer extension. The 59-most band at 2481 relative to the AUG represents full-length
probe sequence; therefore this band is a summation of all GluR2 transcripts 2481 bases and longer. An RNase protection reaction to in vitro synthesized
GluR2 that also extends to 2481 bases is shown in the lef t lane (Ctl, Control). D, Regional distribution in brain of long and short GluR2 transcripts. The
design of probe D, used for RNase protection experiments against 30 mg of RNA isolated from the cerebellum and cortex of each of four rats, allows
for the summation of all GluR2 transcripts 2360 bases and longer into a single band on the gel as well as the identification of short GluR2 transcripts
that initiate at 2340 bases. Results for all four rats are shown at the top and are summarized in the graph at the bottom. Lines in the graph connect the
ratios of long versus short transcripts in cerebellum (CB) and cortex (CX ) for each rat. Bar graphs are the mean 6 SEM of all data and are significantly
different from each other ( p , 0.05, paired t test).
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luciferase expression was observed in primary cortical cultures
when the region delimited by all transcription initiation sites (252
to 1144; Fig. 3A, vertical dashed lines) was included in the pro-
moter construct (Fig. 3B). A similar pattern of promoter activity
was observed when these same constructs were transfected into
primary glia (Fig. 3C) or HeLa cells (data not shown), with the
exception that changes in promoter activity were generally less
marked and, overall, promoter strength relative to SV40 was
much lower than that observed in neurons. From these experi-
ments it seems that GluR2 promoter activity is strongly depen-
dent on cis elements positioned between 2134 and 1320 bp
(Fig. 3A,B).
To define this region of the GluR2 promoter further, we
designed shorter constructs that eliminated portions of this cen-
tral promoter area (2134 to 1320 bp), from either the 59 or the
39 side, and transfected these constructs into primary cortical
neurons and glia. Among these, R2(2134/1147)luc, which
spanned all identified initiation sites, possessed more than twice
the promoter activity of any of the shorter constructs (Fig. 3D,E).
For example, when 44 bp were removed from the 39 end of
Figure 3. 59 and 39 deletion analysis of the GluR2 promoter. A, A series of 59 and 39 deletion constructs was generated by PCR and cloned into the NheI
and BglII sites of the pGL2 basic vector, upstream of firefly luciferase, for transfection into cultured cells. The boundaries of the promoter constructs are
defined relative to the 11 transcriptional initiation site (Fig. 1 A) and are indicated on the lef t, as are the relative locations of TATA and CAAT box
sequences and the GluR2 AUG codon (A; bottom). The area spanning all identified transcription initiation sites is indicated by the vertical dashed lines,
and the 11 initiation site is marked with an arrow. B, Independent constructs were transfected into cortical neurons, and the promoter activity was
normalized to that of SV40 to allow pooling of data from multiple experiments. When a deletion construct eliminated part of the transcription initiation
site region, a significant drop in GluR2 promoter activity was observed. However, no single initiation site was essential for promoter activity. Note that
these cortical neuronal cultures are a mixture of neurons (;60%) and glia (;40%). C, When constructs were transfected into pure cultures of primary
glial cells, similar results were observed except that GluR2 promoter activity was very weak compared with that in neurons. Note the different scales of
the x-axes in B and C. D, Short promoter fragments were made by PCR to identify the minimal boundaries of the GluR2 promoter region necessary for
strong neuronal expression. The locations of identified transcription initiation sites are shown with the same symbols used in Figure 1 A. E, Transfection
of minimal constructs into cultured cortical neurons shows again that elimination of part of the transcription initiation site region (dashed lines in D)
significantly reduced promoter activity. F, Similar results were observed in parallel transfections into cultured glia, and again, promoter activity was weak
compared with that in the neurons. In these glial transfections, the SV40 construct had unusually low promoter activity, resulting in an artificially high
ratio of GluR2 to SV40 activity on the x-axis. Results shown are the mean 6 SEM for 12–33 plasmid transfections in 47 neuronal cultures in B, for 3–9
plasmid transfections in 17 primary glial cultures in C, for 7–20 plasmid transfections in 20 neuronal cultures in E, and for 7–20 plasmid transfections
in 9 glial cultures in F. *p , 0.05 from the R2(2134/1147)luc construct by ANOVA and post hoc Dunnett’s tests. Statistical analysis was not conducted
on data in B and C. The average raw luciferase activity for the R2(2302/1320)luc construct in neurons and glia was 1610 6 160 and 4.1 6 1.2 attomoles
of luciferase per mg of DNA per well, respectively.
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R2(2134/1147)luc to generate R2(2134/1103)luc, promoter ac-
tivity was reduced by 53% in neurons, and likewise, when 124 bp
were removed from the 59 end to make R2(210/1147)luc, pro-
moter activity was reduced by 86% in neurons (Fig. 3E). Similar
effects of these deletions on promoter strength were observed in
primary glia (Fig. 3F) and C6 glioma cells (data not shown),
except promoter activity in glia was again much weaker than that
in primary cortical cultures. The promoter activity of the
R2(2169/1103) construct was identical to that of R2(298/1103)
(Fig. 3D,E), indicating that the sequence between 2169 and 298
bp plays no role in expression under our conditions. Judging from
the activities of the constructs depicted in Figure 3, it appears that
dual regions within the GluR2 central promoter area may be
needed for optimum expression in both cortical neuronal and
glial cells. The upstream region, from 298 to 210 bp, consists of
a GC-rich sequence that includes the putative Sp1/Krox-24 and
NRF-1 elements and minor initiation sites. The downstream
region, from 1103 to 1147 bp, includes a cluster of RACE 59
ends (Fig. 1A) and a consensus sequence for metal element
protein-1 (MEP-1) at bp 1127 to 1133 on the antisense strand.
From these short constructs, we provisionally identify the entire
298 to 1147 sequence as a minimal GluR2 promoter region that
appears sufficient for strong expression in cortical cultures.
We also evaluated the functional role of upstream TATA box
elements using constructs R2(2822/2743)luc and R2(2822/
2332)luc. Both of these constructs produced little or no activity
in both neurons or glia (Fig. 3B,C), eliminating a major role for
the upstream TATA boxes. Similarly, inclusion of the tandem
CAAT boxes at bp 2317 and 2324 in the R2(2822/2134)luc
construct also produced very low activity in neurons and glia.
These functional results support our RACE, RNase protection,
and primer extension findings that failed to demonstrate an
association between transcription initiation sites and upstream
TATA boxes and indicate that the GluR2 gene functions as a
TATA-less promoter, as suggested by Köhler et al. (1994). A
construct, R2(2822/1832)luc, which contained 0.77 kb of 59 pro-
moter sequence, all of exon 1, and part of the GluR2 intron 1, also
showed no significant change in promoter activity in cortical
cultures or primary glia (data not shown), indicating that in
transiently transfected cortical cultures, the first GluR2 intron
does not appear to harbor promoter regulatory elements.
Neural specificity of the GluR2 promoter
We transfected primary cortical neuronal and primary glial cul-
tures, as well as C6 glioma and HeLa cell lines, with the R2(2302/
1320)luc construct to evaluate the neural specificity of the GluR2
promoter. Judged by the percentage of stained cells after trans-
fection with a Rous sarcoma virus (RSV)-b-galactosidase expres-
sion plasmid, typical transfection efficiencies were 0.5–1% for
primary neurons, 6–8% for primary glia, and 10–20% for the
transformed cell lines (Table 1). Even though transfection effi-
ciencies in the cultured neurons were low, the total raw firefly
luciferase activity of the R2(2302/1320)luc construct was quite
strong in these cultures, on the order of 3000 Turner light units
(TLU) per mg of transfected DNA per well (background, ;0.10
TLU/well). This signal corresponds to 1.42 6 0.01 fmols of
luciferase per mg of DNA (n 5 80). We estimate that in each
transfection up to 9000 neurons contribute to the total signal,
based on transfection into triplicate wells, 1 3 106 cells/well
plated, an RSV-lacZ transfection efficiency of 0.5%, and a 60%
fractional neuronal cell population in the culture.
When luciferase activities were normalized to SV40- or the
CMV-promoter activity in each experiment and the average
relative activity was calculated in neurons, primary glia, C6 gli-
oma, and HeLa cells, the R2(2302/1320)luc construct appeared
to be 37–400-fold neuronal-selective. These values, however, are
overestimates caused by the preferred activities of the SV40 and
CMV viral promoters in the non-neuronal cells (Table 1). None-
theless, when viral promoter cell preferences are accounted for,
the R2(2302/1320)luc construct still exhibited a neuronal selec-
tivity of up to 72-fold.
We also analyzed our data on a per-transfected-cell basis by
counting the actual number of RSV-lacZ transfected cells in
parallel wells stained with 5-bromo-4-chloro-3-indolyl-b-
galactopyranoside. Over four experiments, the average R2(2302/
1320)luc promoter activity, per transfected cell, was 0.661 6
0.138 TLU in cortical cultures, 0.022 6 0.002 TLU/cell in cultured
glia, and 0.034 6 0.019 TLU/cell in C6 glioma cells. The average
ratio of cortical neuronal to glial and C6 glioma promoter activ-
ities, per cell, from all experiments, showed that GluR2 promoter
activity was 32.5 6 3.9- and 26.6 6 8.6-fold more active in the
cortical neurons than in cortical glia and C6 glioma cells,
respectively.
To provide another estimate of cell selectivity, transfected
cortical neuronal cultures were costained with an anti-firefly lu-
ciferase antibody and either anti-MAP-2 or anti-GFAP antibod-
ies 1 d after R2(2302/1320)luc transfection. Of 923 luciferase-
positive cells counted, .97% also expressed the neuron-specific
marker MAP-2 (Fig. 4A,B). When immunostainings were con-
ducted in parallel cultures to identify expression in glial cells, only
6 of 645 luciferase-positive cells costained for the glial specific
marker GFAP (data not shown). In these six copositive cells,
luciferase expression was marginally discernible above back-
Table 1. Activities of promoters in the cell types used in this study
Promoter
Cortical neurons Glia C6 glioma HeLa
[fmol of luciferase/mg of DNA/well (n plasmid transfections)]
GluR2 1.42 6 0.01 (80) 0.014 6 0.001 (55) 0.13 6 0.02 (44) 0.27 6 0.02 (43)
SV40 0.28 6 0.03 (62) 4.93 6 1.80 (32) 3.27 6 0.77 (11) 0.90 6 0.34 (29)
CMV 11.0 6 0.22 (40) 36.6 6 8.7 (24) 35.4 6 8.7 (4) 95.7 6 14.3 (22)
NaII 0.11 6 0.03 (15) 5.20 6 0.5 3 1024 (21) 0.05 6 0.01 (21) 0.07 6 0.03 (15)
Transfection efficiency (%) 0.5–1 6–8 10–20 10–20
Cultures were transfected for 5 hr with 1 mg of DNA/well, harvested 24 hr after transfection, and analyzed for luciferase activity. The GluR2 promoter is the
R2(2302/1320)luc construct, and the NaII promoter includes the RE1 silencer described by Kraner et al. (1992). Results shown are the mean 6 SEM for transfections in 27–43
independent culture preparations for neurons, 4–15 for C6 glioma, 11–20 for glia, and 11–15 for HeLa cells for all promoters except NaII. Cortical neuronal cultures are a
mixture of neurons (;60%) and glia (;40%). Transfection efficiencies were determined with an RSV–lacZ construct in three to five cultures. The numbers of cultures used
for NaII promoter transfections were five for neurons and HeLa and seven for C6 glioma and glia.
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ground fluorescence, indicating that even in these glial cells
GluR2 promoter activity was weak. On the other hand, when
cortical cultures were transfected with the CMV-luc construct,
strong anti-luciferase staining in GFAP-positive cells was ob-
served, indicating that transfected glial cells in the primary neu-
ronal cultures were capable of strong luciferase expression (data
not shown). These results together demonstrate that the GluR2
promoter is a strong, neuron-selective promoter that is ;30-fold
stronger in primary neurons than in primary glia.
Because the GluR2 minimal promoter region also showed
strong activity in neurons, we were interested in determining, by
immunofluorescence, whether a minimal promoter construct
could regulate cell-type–selective GluR2 expression in the mixed
neuron–glia cortical cultures. When cortical cultures were trans-
fected with R2(2134/1147)luc, .93% of 146 luciferase-positive
cells costained positive for MAP-2 (Fig. 4C,D), indicating that
elements in this region of the promoter appear sufficient to guide
selective luciferase expression in transfected primary cortical
neurons.
Deletion scan of the GluR2 promoter identifies a
silencer element and a positive regulatory region
To identify elements more precisely within the proximal pro-
moter that regulate GluR2 expression, we made internal deletions
in the R2(2302/1320)luc construct and analyzed these by trans-
fection into cortical neuronal and glial cultures, in parallel, as
above. Most constructs substituted a unique 6 bp restriction
enzyme site for 25–30 bp of GluR2 promoter sequence; the
deletions in DK, DL, and DM were larger (Fig. 5B). For each
experiment, three or more independent plasmid DNA prepara-
tions for each construct were transfected into the cells. By this
analysis, we identified a 25 bp region that, when deleted in the
R2(2302/1320)luc-DB construct, resulted in a significant in-
crease in expression in glial cells but not in neurons (Fig. 5B).
R2(2302/1320)luc-DD, which eliminated the 2146 to 2118 re-
gion, resulted in a 47% increase in promoter activity in neurons
but not in glia, suggesting that this region of the GluR2 promoter
may negatively regulate expression in neurons. Three other 25–30
bp deletion constructs, DG, DH, and DI, caused a significant
reduction in luciferase expression in both neurons and glial cells.
In these cases, promoter activity in each cell type dropped by
35–65% compared with that of the parent R2(2302/1320)luc
construct, even though the basal promoter activity differed ;35-
fold in the two cultures (Fig. 5A). Results found in transfected C6
glioma cells were similar to those in glia (data not shown). The
DG, DH, and DI internal deletion constructs span the region from
264 to 114 bp and include the consensus sequences for Sp1/
Krox-24 and NRF-1. The DL deletion (171 to 1146) also re-
sulted in a reduction in promoter activity that was marginally
greater in glia than in the neuronal cultures. This deletion mutant
eliminated the most 39 initiation site identified by primer exten-
sion and RNase protection (Fig. 2A,B, 2340 band), the 39 cluster
of RACE 59 ends, and a putative MEP-1 element. In contrast, the
deletion of other major transcription initiation sites in the DJ, DK,
and DM constructs did not reduce luciferase expression.
The pattern of expression from these internal deletion con-
structs complements our findings from the external 59 and 39
deletion series (Fig. 3) and allowed us to provisionally eliminate
up to 364 bases of the GluR2 promoter from further consider-
ation. We focused our attention on the non-neural silencer
element identified in deletion R2(2302/1320)luc-DB and the
positive regulatory region identified in deletions R2(2302/
1320)luc-DG, -DH, and -DI.
The GluR2 silencer is a cell-specific modulator of
expression, not a switch
Inspection of the GluR2 promoter sequence revealed a 21 base
element with 71% identity to both the rat NaII-RE1 (Maue et al.,
1990; Kraner et al., 1992) (Fig. 6A) and the rat SCG10 gene
neuron-restrictive silencer element (NRSE) (Mori et al., 1992).
This RE1/NRSE-like element in the GluR2 promoter is located
on the antisense strand at bp 2174 to 2194 (Fig. 1A) and had
been deleted entirely in the R2(2302/1320)luc-DB construct
(Fig. 5B). Given the sequence similarity, we investigated the role
Figure 4. Minimal GluR2 promoters restrict
luciferase expression to neurons. The GluR2
promoter constructs R2(2302/1320)luc (A, B)
or R2(2134/1147)luc (C, D) were transfected
into day 5 primary cortical neuronal cultures
and double-immunostained 24 hr later with
rabbit anti-luciferase (anti-luc) (A, C) and
mouse anti-MAP-2 (B, D) primary antibodies
as described in Materials and Methods. A, A
cell with neuronal morphology stained positive
for luciferase expression, as detected by the
goat anti-rabbit FITC-conjugated secondary
antibody. B, The same cell in A is also positive
for the neuronal-specific antigen MAP-2 (ar-
row), detected with a donkey anti-mouse Texas
Red-conjugated secondary antibody. From five
R2(2302/1320)luc transfections in which 923
luciferase-positive cells were counted, .97%
were clearly positive for the MAP-2 antigen. C,
Another cell with neuronal morphology was
positive for luciferase expression, as described
in A, except the culture was transfected with the
R2(2134/1147)luc minimal promoter con-
struct. D, The same field as in C identified the
transfected cell as MAP-2–positive (arrow).
From two R2(2134/1147)luc transfections in
which 146 luciferase-positive cells were
counted, .93% were clearly MAP-2–positive.
Scale bar: A–D, 50 mm.
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of the putative GluR2 silencer in regulating R2(2302/1320)luc
promoter activity in neuronal and non-neuronal cells. When the
entire GluR2 silencer was replaced with an NsiI restriction site
(Fig. 6A, DB) or different 6 bp stretches were substituted by 6 bp
EcoRI or EcoRV restriction sites (Fig. 6A, dRI, dRV), significant
two- to threefold increases in R2(2302/1320)luc activity were
observed in glia and C6 gliomas (Fig. 6B). Similar results were
observed when these same mutations were introduced into the
context of a larger R2(2822/1320)luc promoter construct (data
not shown). No changes in neuronal expression were observed by
any of these mutations (Fig. 6B), demonstrating that silencing
activity was specific to non-neuronal cells alone. These results are
consistent with known RE1/NRSE silencers in other genes, in
which short internal missense mutations are sufficient to disrupt
silencing activity in non-neuronal cells (Kraner et al., 1992; Mori
et al., 1992; Li et al., 1993; Mieda et al., 1997).
Because the GluR2 silencer was only 71% identical with the
NaII-RE1 element and the effect of deleting this element was
moderate (two- to threefold) when compared with homologous
RE1/NRSE silencers (Kraner et al., 1992; Mori et al., 1992; Li et
al., 1993; Wood et al., 1996; Mieda et al., 1997), we compared the
ability of the GluR2 and the NaII-RE1 silencers to repress both
GluR2 and NaII promoter (NaIIluc) activities in glia, C6 glioma,
and neuronal cells. When the GluR2 silencer was mutated to that
of the NaII-RE1 sequence in the context of the GluR2 promoter,
this substitution resulted in a 30–47% decrease in promoter
activity in non-neuronal cells (Fig. 6C, black bars) relative to that
of the unmutated R2(2302/1320)luc control. Conversely, when
the NaII silencer in the context of the NaII promoter was mutated
to that of the GluR2 silencer sequence, promoter activity was
increased by 54–61% in non-neuronal cells (Fig. 6C, gray bars),
indicating that repression by the NaII silencer was lessened by
substitution with the GluR2 silencer. The effect of swapping these
silencer elements was specific to the non-neuronal cells because
no changes in neuronal expression were observed. For all of these
constructs, the flanking nucleotide sequences and the orientation
of the silencer element in each minimal promoter context were
carefully preserved (Fig. 6C, top). Together, these results dem-
onstrate that the NaII-RE1 silencer is more effective than the
GluR2 silencer and indicate that their relative strengths are
because of differences in their nucleotide sequence rather than
differences in silencer orientation or in the context of the pro-
moters in which they reside. This conclusion is further supported
by the observation that both the NaII and the GluR2 minimal
promoter constructs used for these experiments, in the absence of
either silencer, had similar promoter activities in glia (2.0 and
Figure 5. Mutation sensitive scan of the proximal GluR2 promoter identifies both positive and negative regulatory regions. A, The promoter activity
of the base construct R2(2302/1320)luc in cultured neurons (N; n 5 63) and glia (G; n 5 46), relative to SV40luc activity, is shown. Data are the mean 6
SEM combined from all experiments. The average raw luciferase activity recovered from neurons and glia for the unmutated R2(2302/1320)luc control
was 1320 6 120 and 31 6 14 attomoles per mg of DNA per well, respectively. B, A series of short internal deletions (DA through DN, typically 24–31
bp long, except DK, DL, and DM) were generated by replacement with unique 6 bp restriction sites in the R2(2302/1320)luc GluR2 context. All deletions
were generated by PCR and are shown schematically at the top. Dashed lines indicate the sequence deleted for the indicated construct (uppercase letters).
Gray and solid circles and open triangles on the line indicate the locations of primer extension, RNase protection, and RACE 59 ends, respectively. Open
boxes identify the locations of Sp1/Krox-24 and NRF-1 consensus sequences; the black box identifies the GluR2 silencer that is homologous with the
RE1/NRSE silencers. The effect of each internal mutation on promoter activity in cultured cortical neurons and glia is shown. Luciferase activity was
normalized to that of the unmutated R2(2302/1320)luc control construct. Note the log scale on the y-axis. The R2(2302/1320)luc-DB construct resulted
in a significant twofold increase in promoter activity in glia. Likewise the R2(2302/1320)luc-DD deletion resulted in a significant increase in promoter
activity in neurons. Three other deletions, R2(2302/1320)luc-DG, -DH, and -DI, resulted in significant decreases in promoter activity in both glia and
neurons. This internal deletion scan identified both a silencer region that negatively regulates GluR2 promoter activity in glia and a larger 78 bp region
that positively regulates promoter activity in both neurons and glia. Data shown are the mean 6 SEM for 6–18 plasmid transfections in 21 cultured
neuronal preparations and for 6–8 transfections in 18 cultured glial preparations. lucif, Luciferase. *p , 0.05 and **p , 0.01 indicate significance from
the control construct by ANOVA and post hoc Dunnett’s tests.
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3.5% of SV40, respectively) and C6 glioma cells (16.5 and 18.1%,
respectively).
We also investigated whether the GluR2 silencer could interact
with a known repressor factor, REST (Chong et al., 1995), also
known as neuron-restrictive silencer factor (NRSF) (Schoenherr
and Anderson, 1995) or X2 box repressor (XBR) (Scholl et al.,
1996), by cotransfecting the pCMV-RESTexpress plasmid with
GluR2 promoter constructs into cultured neurons (Fig. 6D).
There are three important considerations in the design of this
cotransfection experiment. First, it is important to compare the
effect of REST on normal and mutated GluR2 silencers to elim-
inate indirect effects of REST on other regions of the GluR2
promoter or on the expression of other endogenous genes. Sec-
ond, it is necessary to cotransfect with an empty CMV vector,
pcDNA3, as a control for indirect effects of the CMV promoter
on luciferase expression. Third, it is necessary to demonstrate
that simple inclusion of additional DNA in the transfection mix
does not change transfection efficiency. Regarding the latter,
luciferase activity was found to be linearly related to the amount
of input R2luc DNA between 0.1 and 1.5 mg/well, and luciferase
Figure 6. A weak GluR2 silencer interacts with the repressor REST. A, Schematic showing the location and antisense orientation of the silencer in the
GluR2 promoter. The native (GluR2) and mutagenized silencer elements introduced into the R2(2302/1320)luc promoter construct are listed. Dashes
represent deleted sequence, and lowercase, boldface type represents substitution mutations. The DB mutation is the same mutation as the internal deletion
construct depicted in Figure 5. The NaII-RE1 sequence shown is the Type II Na channel RE1 silencer (Kraner et al., 1992), which differs from GluR2
in six positions. B, Functional analysis of silencer mutations on GluR2 promoter activity in primary cortical neurons, primary cortical glia, and C6 glioma
cells. In neurons, no mutation resulted in a significant change in promoter activity from that of the R2(2302/1320)luc control. In primary glia and C6
glioma cells, all three silencer mutations resulted in two- to threefold increases in GluR2 promoter activity. Data shown are the mean 6 SEM for 12–24
plasmid transfections in neurons, 14–22 plasmid transfections in glia, and 6–34 plasmid transfections in C6 gliomas from 10, 9, and 7 culture preparations,
respectively. *p , 0.05 from the control by ANOVA and post hoc Dunnett’s test. The error bar for the control (R2) represents the average SE among
control plasmids. C, Promoter context independence of the GluR2 silencer. The GluR2 silencer was replaced by the NaII-RE1 silencer (see A) in the
context of the R2(2302/1320)luc promoter. Likewise, the NaII-RE1 silencer was replaced by the GluR2 silencer in the context of the NaII promoter
construct. These constructs were transfected into primary neurons, glia, and C6 glioma cells. The NaII-RE1 silencer in the context of the GluR2 promoter
(black bars) reduced promoter activity by 30–47% relative to that of the unmutated R2(2302/1320)luc control (open bars defined as 100%) in glia and
C6 glioma cells. In contrast, the GluR2 silencer in the context of the NaII promoter ( gray bars) increased promoter activity by 54–61% relative to that
of the unmutated NaII minimal promoter control (open bars also) in glia and C6 glioma cells. The effect of the alternative silencer in each of the
promoters was significant from their respective controls; *p , 0.05, Student’s t test. Data shown are the mean 6 SEM for 8–9 plasmid transfections in
neurons and 8–15 transfections in glia and C6 gliomas, all from three to five culture preparations for each cell type. D, Cotransfection of REST represses
GluR2 promoter activity in neurons. The GluR2 silencer in the context of R2(2302/1320)luc was either unchanged ( gray circles), deleted (open circles),
replaced by the NaII silencer (black circles), or replaced by tandem GluR2 silencers (hatched circles) and then cotransfected into cultured cortical neurons
with 0.75 mg of pCMV-RESTexpress per well or the pcDNA3 empty vector. The amount of R2(2302/1320)luc reporter plasmid was varied from 0.1
to 1.0 mg/well, and all tubes were balanced to 1.75 mg of total DNA/well with carrier DNA (pBluescript). REST cotransfection reduced GluR2 promoter
activity by 20–42% from that of the pcDNA3 control in neurons in a silencer-dependent manner. This effect by REST was observed at all concentrations
of input GluR2 promoter DNA tested (D, lef t). When luciferase activities were normalized to those of the silencer-deficient construct R2(2302/
1320)luc-DB and pooled (right, open bar), REST coexpression reduced GluR2 promoter activity in neurons by an average of 37% (right, gray bar). Results
are the mean 6 SEM for 3–14 cotransfections in 14 culture preparations. Identical results were obtained using two independent preparations of
pCMV-RESTexpress, pcDNA, and pBluescript plasmid DNA. *p , 0.05 or better from all other groups at the designated amount of input DNA (lef t,
ANOVA and post hoc Dunnett’s) or from the silencer-deficient construct (right, Student’s t test).
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activity was not influenced by adding carrier pBluescript DNA
(data not shown). The cotransfection experiments are summa-
rized in Figure 6D. The RESTexpress plasmid in the transfection
cocktail was fixed at 0.75 mg/well, the GluR2 promoter construct
was varied from 0.1 to 1.0 mg/well, and all tubes were balanced
with carrier DNA (pBluescript) to a final mass of 1.75 mg of DNA
per transfected well. Compared with the pcDNA3 control, the
pCMV-RESTexpress cotransfections resulted in a consistent 20–
42% reduction in neuronal R2(2302/1320)luc promoter activity
when the reporter construct contained an intact GluR2 or NaII-
RE1/NRSE silencer element (Fig. 6D, lef t). REST coexpression
actually increased GluR2 promoter activity in neurons trans-
fected with the GluR2 construct lacking a silencer, presumably
because of an action of REST on other genes. Thus, when the
data across all input DNA amounts were pooled and normalized
to the activity of the construct lacking the GluR2 silencer, a
significant 37% REST-mediated reduction in GluR2 promoter
activity was observed (Fig. 6D, right). The addition of an extra
GluR2 silencer element, or the substitution of the GluR2 silencer
by the NaII-RE1 silencer, did not significantly enhance the effect
of REST. Presumably the NaII-RE1 element was no more effec-
tive than the GluR2 silencer because 0.75 mg of pCMV-
RESTexpress was saturating in both cotransfections. The consis-
tent ability of REST to reduce GluR2 promoter activity in
neurons in a silencer-dependent manner indicates that in intact
cells the REST repressor can bind the GluR2 silencer to modify
GluR2 promoter activity.
Functional NRF-1 and Sp1 cis elements in the GluR2-
positive regulatory region
Based on the internal deletion scan, it was concluded that ele-
ments within the R2(2302/1320)luc-DG, -DH, and -DI deletions
must contribute to GluR2 promoter activity. As shown in Figures
1A and 5B, these regions harbor consensus sequences for Sp1/
Krox-24 and NRF-1 elements and, within the DH deletion, an
element with 75% identity with the partial dyad (Patankar et al.,
1997). We introduced substitution mutations into or near these
elements to determine specifically whether these elements were
necessary for GluR2 promoter activity in neurons. When six
bases of the NRF-1 element were substituted with a BglII site
(AGATCT) to generate the R2(2302/1320)luc-di1 construct
(Fig. 7A), a 46 and 26% drop in promoter activity was observed
in cortical neurons and cortical glia, respectively (Fig. 7B, gray
bars). The effect of this mutation approaches the effect observed
for the larger R2(2302/1320)luc-DI deletion in neurons and is
consistent with the effect of mutations introduced into other
NRF-1 elements (Virbasius et al., 1993; Seelan et al., 1996). The
R2(2302/1320)luc-DK deletion, generated by excising the se-
quence between two natural BssHII sites, eliminated all of the
sequence in the DI deletion except for the NRF-1 consensus
element, and yet this construct did not decrease but, instead,
slightly elevated promoter activity in neurons and glia (Fig. 7B,
black bars). This result strongly suggests that the consensus
NRF-1 sequence is a functional regulatory element in the GluR2
promoter. However, because the NRF-1 element is GC-rich and
might therefore interact with factors other than NRF-1 (e.g.,
Sp1), we cotransfected the NRF-1 transcription factor (under the
CMV promoter) with the unmutated R2(2302/1320)luc control
construct and the mutated R2(2302/1320)luc-DI and -di1 con-
structs into neurons (Fig. 7C). NRF-1 cotransfection increased
GluR2 promoter activity approximately twofold, but only when
the GluR2 promoter construct contained an unmutated NRF-1
cis element (Fig. 7C). The lack of a larger effect by the cotrans-
fected NRF-1 may be attributable to the presence of endogenous
NRF-1 or some other transcription factor in the cortical neurons.
These results indicate that the NRF-1 cis element sequence
supports positive GluR2 promoter activity in neurons and sug-
gests, but does not prove, that the NRF-1 transcription factor is a
component of the transcriptional complex in vivo.
The NRF-1 element partially overlapped the R2(2302/
1320)luc-DH deletion construct (Fig. 7A), and also because the
nucleotide sequence within the DH deletion resembled the partial
dyad motif described previously (Patankar et al., 1997), we intro-
duced additional short substitution mutations into this portion of
the GluR2 promoter, again in the context of R2(2302/1320)luc
(Fig. 7A). All three substitution mutations, R2(2302/1320)luc-
dh1 (TCTAGAT), -dh2 (CGAGT), and -dh3 (AGATC), were
without significant effect on GluR2 promoter activity in both
neurons and glia (Fig. 7B, hatched bars), indicating that neither
the partial dyad nor another unidentified element in this region of
the promoter contributed to GluR2 promoter activity. The strong
effect of the large DH deletion may be caused by disruption of a
single base of the NRF-1 element or, more likely, caused by
disruption of an appropriate architectural distance between the
functional NRF-1 and Sp1/Krox-24 (see below) elements.
A third consensus element within the GluR2-positive regula-
tory region that we investigated by mutation analysis was the
consensus Sp1 and Krox-24 sequence at 247 to 260 bp. This
sequence was entirely deleted in the internal deletion R2(2302/
1320)luc-DG construct, resulting in a significant 35–50% reduc-
tion in promoter activity in both neurons and glia (Fig. 5B). When
four bases of the consensus element were mutated (TCTA) by
base substitution to generate R2(2302/1320)luc-dg1, a nearly
identical reduction in GluR2 promoter activity was observed (Fig.
8A,B), suggesting that it is the consensus Sp1/Krox-24 sequence,
and not the immediate flanking sequence within the larger DG
deletion construct, that is important for GluR2 promoter activity.
To differentiate between an Sp1 and Krox-24 component for
GluR2 expression in neurons, we prepared nuclear extracts from
cultured cortical neurons and combined these extracts with 32P-
end-labeled double-stranded oligonucleotide probes in vitro. Oli-
gonucleotide probes consisting of the DG and DH sequences
shown in Figure 8A produced different protein–DNA complexes
in nondenaturing gel mobility shift experiments (Fig. 8C). Probe
G formed three major complexes that were effectively competed
away by 200-fold molar excess of cold probe (compare Fig. 8C,
lanes 2–3). Excess Sp1 oligonucleotide competed away bands 1a
and 1b but was less effective on band 1c (Fig. 8C, lane 4), and
addition of an anti-Sp1 antibody to the incubations supershifted
the complex, indicating that Sp1 is part of the protein complex
recruited by probe G (Fig. 8C, arrow, lane 5). The addition of
anti-Krox-24 antibody (Fig. 8C, lane 6) or competing Krox-24
oligonucleotides (Fig. 8C, lane 7) to the incubations had no effect
on complex formation with probe G. The mutant dg1 oligonucle-
otide was a poor competitor of Sp1 binding in vitro because
30–200-fold excess oligonucleotide only weakly decreased protein
binding to probe G (Fig. 8C, lanes 18–20), compared with com-
petition by 30–200-fold excess cold probe G DNA (Fig. 8C, lanes
15–17), consistent with the conclusion that the Sp1 element in
Figure 8A is the Sp1-binding site required for functional pro-
moter activity.
Similar in vitro binding experiments with probe H resulted in
the formation of a single complex that was competed away with
excess unlabeled probe H DNA (Fig. 8C, lane 10). This protein–
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DNA complex was not disrupted by competing unlabeled probe G
(Fig. 8C, lane 11) or Krox-24 DNA (data not shown), nor was it
part of the complex supershifted by coincubation with anti-Sp1
(Fig. 8C, lane 12) or anti-Krox-24 antibodies (data not shown).
The different banding patterns observed for the G and H probes
as well as the nonoverlapping competition between the two
probes indicate that the protein complex recruited by sequence
contained within DG of the GluR2 minimal promoter region
includes Sp1.
DISCUSSION
We cloned the proximal promoter region of the rat GluR2 gene
and identified three regulatory elements that govern GluR2 pro-
moter activity in transfected cortical cultures, and we confirm the
location of a major transcription initiation site 2429/2430 nucle-
otides from the AUG codon, as described previously (Köhler et
al., 1994). The new conclusions of this study are (1) GluR2
transcription initiates from multiple major sites spread over .141
bp, (2) initiation sites are used differentially in adult cortical and
cerebellar neurons, (3) GluR2 promoter activity is 30-fold stron-
ger in cultured cortical neurons than in primary glia or C6 glioma,
(4) promoter activity is regulated by both an RE1/NRSE-like
silencer element and two positive regulatory elements (NRF-1
and Sp1) separated by a nucleotide bridge sequence, and (5) the
GluR2 silencer is a weak silencer relative to the NaII RE1
silencer but still contributes to the neuronal specificity of the
GluR2 promoter. These findings identify the first functional
regulatory elements in the GluR2 promoter and point to a com-
plex transcriptional control region for GluR2 expression in
neurons.
Functional implications of multiple GluR2 promoters
Our primer extension and RNase protection results identified
multiple transcription initiation sites resulting in lengthy (340–
481 bases) GluR2 mRNA leader sequences. These, and addi-
tional results (Fig. 2), suggest the existence of multiple GluR2
Figure 7. Contribution of the NRF-1 element to GluR2 promoter activity. A, Schematic of the positive regulatory domain, 264 to 138 bp, of the GluR2
promoter region is shown with regulatory cis elements as shaded bars above the sequence; gray and solid circles and triangles signify some of the
transcription initiation sites described in the Figure 1A legend. Internal deletion and substitution mutations introduced into the R2(2302/1320)luc
construct are shown by open bars below the sequence and identified. Deletion mutants are signified by “D,” and base-for-base substitution mutations are
signified by “d.” Deletion constructs are the same as those in Figure 5. B, Multiple plasmid DNA preparations for each construct were transfected into
cultured cortical neurons or cortical glia, and luciferase activity was measured 1 d later. Promoter activity of the mutated constructs was compared with
that of the R2(2302/1320)luc control construct (Con). The dh1, dh2, and dh3 substitution mutations had no effect on GluR2 promoter activity in neurons
and glia and did not replicate the effect of the larger DH deletion construct, indicating that the effect of the DH deletion is not dependent on nucleotide
sequence (i.e., the partial dyad). In contrast, both the DI and di1 mutations resulted in a reduction in promoter activity in neurons and glia, whereas the
DK and dh3 constructs that modify the sequence immediately adjacent to the NRF-1 element were without effect. Together these results identify the
consensus NRF-1 as a positive regulator of GluR2 promoter activity. Results shown are the mean 6 SEM for 8–12 plasmid transfections into four to
five cultures. *p , 0.05 from the control group by ANOVA and post hoc Dunnett’s tests. C, One microgram of a plasmid expressing the NRF-1
transcription factor (black bars) or an empty pcDNA3 vector (cross-hatched bars) was cotransfected with 0.5 mg of R2(2302/1320)luc (Con) or the di1
or the DI mutation constructs into neurons. Data were normalized to the activity of a parallel SV40-luc transfection in each experiment. The NRF-1
cotransfection increased promoter activity in the control construct but not in those constructs with a compromised NRF-1 cis element. Results are the
mean 6 SEM in five neuronal cultures. *p , 0.05 from the pcDNA3- (no NRF-1) transfected group, Student’s t test.
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promoters. First, the observed wide distribution of transcriptional
start sites (.141 bp) is uncommon even for TATA-less promoters
but is shared by other CNS genes in which multiple promoters
choreograph appropriate developmental or tissue-specific gene
expression (Timmusk et al., 1993; Pathak et al., 1994) or increase
the complexity of mRNA transcripts within the same tissue type
(Liu and Fischer, 1996). Second, we found that the number and
relative use of major GluR2 transcription initiation sites in cortex
were different from that in cerebellum (Fig. 2C,D). These re-
gional differences in initiation site usage perhaps reflect the
greater variety of neuronal cell types found in cerebral cortex
versus cerebellum and that distinct subpopulations of cortical
neurons may transcribe GluR2 from different initiation sites.
Alternatively, transcription initiation could occur at multiple sites
in each cortical neuron, thereby increasing the variety of GluR2
transcripts expressed per cell. In either case, the usage of the
upstream transcriptional start sites is cell-selective, consistent
with multiple promoters. Thirdly, no single initiation site was
completely essential for GluR2 promoter activity based on our
internal deletion scan (Fig. 5), indicating that RNA polymerase
can initiate GluR2 transcription from multiple, independent sites.
Depending on the site of transcription initiation, GluR2 mRNAs
will contain variably long GC-rich 59-UTR leaders, an imperfect
GU repeat (40 nucleotides), and from two to five upstream
out-of-frame AUG codons. Unusually long 59-UTR sequences
(Kozak, 1987) with high GC content and upstream AUG codons
can interfere with appropriate mRNA translation (see Geballe
and Morris, 1994). Indeed, we have found that sequences in the 59
Figure 8. Identification of an Sp1 element required for GluR2 promoter activity. A, Schematic of the positive regulatory domain, 264 to 138 bp, of
the GluR2 promoter is shown with identified cis elements as shaded bars above the sequence; gray and solid circles and triangles signify some of the
transcription initiation sites described in the Figure 1A legend. Internal deletion and substitution mutations introduced into the R2(2302/1320)luc
construct are identified by open bars below the sequence. Deletion mutants are signified by “D,” and substitution mutations are signified by “d.” Deletion
constructs are the same as those in Figure 5. B, Multiple plasmid transfections were made into cortical neurons or cortical glia, and promoter activity
was measured 1 d later. Both the DG deletion and the dg1 substitution mutation resulted in significant reductions in GluR2 promoter activity in both
cell types. These results suggest that the Sp1/Krox-24 consensus element from 247 to 260 positively regulates GluR2 promoter activity. Results shown
are the mean 6 SEM for eight to nine plasmid transfections in three cultures. *p , 0.05 from the control group by ANOVA and post hoc Dunnett’s tests.
C, Nuclear extracts (8 mg/ lane; Extr) were prepared from cultured cortical neurons and incubated with 32P-end-labeled double-stranded oligonucleotide
probes (;0.3 nM) at room temperature for 15 min. Probe G (lanes 1–7 and 13–20; same sequence as DG in A) resulted in the formation of three
DNA–protein complexes (1a, 1b, and 1c), which were effectively competed away with 200-fold excess (Comp) unlabeled probe G oligonucleotide (lane
3). Excess competitor Sp1 oligonucleotides also competed for probe G binding (lane 4), and an anti-Sp1 antibody supershifted part of the complex (lane
5). A Krox-24 oligonucleotide (Kx; lane 7) and an anti-Krox-24 antibody (lane 6) had no effect. When the DH sequence was used as probe H (lanes 8–12),
a different protein–DNA complex was resolved. This complex was competed away with excess cold probe H DNA (lane 10) but not excess cold probe
G (lane 11), nor was it supershifted by anti-Sp1 (lane 12) antibodies. In a separate experiment, 30–200-fold excess competitor oligonucleotides were added
to similar probe G-binding incubations (lanes 13–20). Here, excess cold probe G (lanes 15–17) was an effective competitor at displacing the protein from
the complex, whereas excess dg1 (lanes 18–20) was not. These results demonstrate that the Sp1/Krox-24 consensus element identified in A is important
for GluR2 promoter activity and for Sp1 binding.
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ends of the longest GluR2 transcripts profoundly impair transla-
tion in oocytes and in a cell-free translation assay (Myers et al.,
1997), further emphasizing the importance of determining the
cell types and conditions under which the various upstream start
sites are used. Thus, whether the GluR2 mRNA is translationally
suppressed is determined in part by transcriptional regulation.
Modulation of GluR2 expression by an
RE1/NRSE-like silencer
The neural-specific expression of the type II sodium channel and
SCG10 genes is controlled primarily by a multizinc finger repres-
sor, termed REST or NRSF, that binds to RE1/NRSE silencer
elements in their 59 promoter regions. REST/NRSF expression is
expressed in non-neural cells (Kraner et al., 1992, Chong et al.,
1995; Schoenherr and Anderson, 1995) but also has been detected
by in situ hybridization in neurons in brain including cortex (Palm
et al., 1998). We have shown that the GluR2 59 promoter region
contains a functional RE1/NRSE-like silencer that similarly re-
presses GluR2 promoter activity specifically in non-neural cells
(Fig. 6). However, in contrast to initial descriptions of dominant
RE1/NRSE silencers that suppress expression by 10-fold or more
(Maue et al., 1990; Kraner et al., 1992; Li et al., 1993), the GluR2
silencer only moderately represses promoter activity by less than
threefold. Consistent with a previous report that compared si-
lencers from multiple genes relating silencer activity with se-
quence homology to the consensus element (Schoenherr et al.,
1996), our silencer-swapping experiments between GluR2 and
sodium channel promoters (Fig. 6C) showed that enervation of
the GluR2 silencer is attributable to nucleotide sequence differ-
ences rather than to contextual effects such as orientation, dis-
tance from initiation sites, or 59- and 39-flanking sequences.
Thus the GluR2 silencer operates more like a modulator of
expression than like a dominant switch as indicated for other
genes (Kraner et al., 1992; Mori et al., 1992; Li et al., 1993).
Under the conditions of our experiments, the GluR2 silencer
plays little or no role in regulating GluR2 expression in cortical
neurons because deletion of the silencer does not alter promoter
activity in cultured cortical neurons. However, the GluR2 silencer
remains a potential target for REST, REST-like transcription
factors, or REST splice variants that are expressed in neurons
basally or after seizure (Palm et al., 1998). Indeed, we have shown
that REST can decrease GluR2 promoter activity in neurons
when introduced by cotransfection (Fig. 6D). A recent report
showed that an homologous sequence in the rat nicotinic b2
subunit gene can operate either as an enhancer or as a silencer
depending on its position in the promoter (Bessis et al., 1997),
raising additional potential roles for RE1/NRSE-like elements in
regulating transcription.
Positive regulatory elements define a GluR2 minimal
promoter region
By transient transfection, the GluR2 promoter is 30-fold stronger
in primary cortical neuronal cultures than in cortical glial cultures
or C6 glioma cells. As judged by luciferase activity measurements
in transfected cells, the GluR2 silencer contributes up to three-
fold neuronal selectivity, but shorter constructs lacking the si-
lencer still show up to a 10-fold neuronal preference after nor-
malization to SV40 (Fig. 3D–F). When cortical cultures were
transfected with the minimal R2(2134/1147)luc construct,
;93% of the luciferase-immunopositive cells were MAP-2–
positive neurons, further indicating that the minimal promoter
region exhibits strong neuronal selectivity (Fig. 4). We identified
positive-acting Sp1 and NRF-1 elements in the GluR2 minimal
promoter region by internal deletion and substitution mutation of
candidate sites (Figs. 7, 8). Functional Sp1 elements are com-
monly found in TATA-less, GC-rich promoter regions and have
been shown in other genes to interact with an NRF-1 element to
coordinate promoter activity (Seelan et al., 1996). Sequence be-
tween the Sp1 and NRF-1 elements (labeled DH in Figs. 7, 8) may
serve as a spatial linker or interelement bridge to align transcrip-
tion factors bound to the Sp1 and NRF-1 cis elements on the
GluR2 gene, because deletion of the entire sequence reduced
promoter activity by ;75%, but short substitution mutations
designed to identify regulatory elements had no effect (Fig. 7B).
Functional NRF-1 elements are positioned near transcription
initiation sites of genes for several rate-limiting enzymes (Chau et
al., 1992; Virbasius et al., 1993) and mitochondrial genes (Virba-
sius et al., 1993; Seelan et al., 1996), suggesting that NRF-1 may
serve to coordinate a variety of cellular processes by upregulating
the expression of key proteins in metabolic pathways. In the
GluR2 gene, Sp1 and NRF-1 elements also reside near major
transcription initiation sites and contribute significantly to GluR2
promoter activity. Despite these findings, however, neither ele-
ment showed cell-type selectivity in transient expression assays
(Figs. 5, 7, 8). Because Sp1 and NRF-1 transcription factors are
expressed in a variety of tissues including brain (Hagen et al.,
1992; Gopalakrishnan and Scarpulla, 1995), the lack of neural
specificity observed in these assays may not be unexpected. A
functional element in the promoter of the brain-specific aldolase
C gene has been shown to bind non-neural transcription factors in
vitro yet was still able to mediate brain-specific expression in
transgenic mice (Thomas et al., 1995).
Minimal promoter regions are generally defined as short se-
quences that are sufficient for basal promoter activity but do not
regulate expression in a cell-specific manner. However, minimal
promoters of GluR2, GAP-43, MAP-1B, and brain-specific aldo-
lase C genes seem to direct neural-specific expression in primary
neurons, neuronal cell lines, and transgenic mice (Nedivi et al.,
1992; Thomas et al., 1995; Liu and Fischer, 1996; Weber and
Skene, 1997). Two major mechanisms conferring neural-specific
gene expression have been proposed. First, neural specificity can
be achieved by the actions of a distant and dominant silencer,
such as the RE1/NRSE, on an unselective basal promoter
(Kraner et al., 1992; Mori et al., 1992), or second, neural speci-
ficity can be conferred by elements near initiation sites within a
minimal promoter region (Nedivi et al., 1992; Thomas et al.,
1995; Liu and Fischer, 1996; Weber and Skene, 1997). The GluR2
gene seems to use both proposed mechanisms, although the
minimal promoter region seems to dominate.
How can the minimal promoter sequence consisting of #245 bp
show strong neuronal preference without a clear contribution
from individual elements (Fig. 5)? One explanation may be that
the gain for promoter activity is higher in neurons than in glia
because of the presence of a neural-specific transcription factor,
or adaptor protein, that can bind either common cis regulatory
elements or the general transcription factors. For example, Sp3
and Sp4 are additional members of the Sp1 transcription factor
family that bind sequence elements identical to those that Sp1
binds but are expressed predominantly in brain (Hagen et al.,
1992). An alternative explanation could be that transcripts are
initiated from different sites in glia than in neurons and that the
translation rate or stability of GluR2 mRNA in glia is significantly
reduced compared with that in neurons. These latter interpreta-
tions are, however, unlikely because even the short constructs
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lacking specific 59 initiation sites still showed neuronal preference
(Fig. 3D–F). Finally, a neural-specific element in the GluR2
promoter may exist but reside outside the region analyzed by our
internal deletion scan.
Findings from this study provide a necessary foundation for
understanding the transcriptional regulation of GluR2 expression
in neurons. In particular, it will be of interest to determine the
biological roles of the identified Sp1, NRF-1, and silencer regu-
latory elements in mediating changes in GluR2 levels after ische-
mia and status epilepticus. These results also suggest a strategy to
determine why some CNS interneurons express low levels of
GluR2, affecting the properties of AMPA receptor-mediated
synaptic transmission. One approach would be to determine
whether appropriate neuronal expression of the NRF-1, Sp1, Sp3,
Sp4, and/or REST transcription factors correlates with the GluR2
expression level in different cell populations.
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